The staggering cost of building AI infrastructure is pushing tech giants and startups alike into every corner of the debt market, from blue-chip bonds to private credit, reshaping investment portfolios and introducing new risks.
A coalition of major international NGOs is refusing to comply with Israeli orders to hand over detailed staff information, calling it a safety risk and an obstruction of aid, as tensions escalate following the expulsion of Médecins Sans Frontières.
As Bitcoin grapples with volatility below $80,000, a packed U.S. economic calendar—featuring key jobs reports and MicroStrategy's Q4 earnings—is poised to dictate the cryptocurrency's near-term trajectory by shaping Federal Reserve policy expectations.
As Israel now acknowledges over 70,000 killed in Gaza, rights advocates argue that early Western political and media skepticism dehumanized Palestinians and delayed a full reckoning with the war's human cost.
The Israeli government has ordered Médecins Sans Frontières (MSF) to cease operations in Gaza by the end of February, citing the aid group's refusal to hand over details of its Palestinian staff—a move critics decry as a dangerous politicization of humanitarian aid.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
Despite a trimmed price target from B. Riley, WhiteFiber Inc. (WYFI) secures a pivotal 10-year colocation agreement expected to generate $865 million, spotlighting its role in the expanding AI infrastructure sector.
From a $10 direct listing to a $150 S&P 500 constituent, Palantir's journey has been fueled by the AI boom. As government and commercial demand surge, analysts project staggering growth. But with sky-high valuations, the path forward requires navigating lofty expectations.
As demand for AI infrastructure surges, Broadcom's custom chip business positions it for sustained growth, with analysts highlighting its potential for long-term portfolio gains despite its absence from some top stock lists.
Doctors Without Borders (MSF) has definitively rejected an Israeli order to hand over sensitive staff information, following months of failed negotiations. The move comes amid a wider crackdown on aid groups and a devastating toll on healthcare workers in the conflict.
Planet Labs secures a strategic enterprise agreement with the Slovenian government, expanding its public sector footprint with applications in agriculture, urban development, and disaster preparedness. The deal comes as investors scrutinize the company's premium market valuation amidst growing competition in the Earth observation sector.
Rosenblatt Securities initiates coverage on Credo Technology with a Neutral rating and a $170 price target, highlighting its strong position in high-speed connectivity for AI infrastructure while flagging competitive pressures. The note follows a more bullish target hike from Barclays earlier in the month.
Equifax is expanding beyond traditional credit reporting with a new suite of AI-powered fraud detection and income verification tools. While this strategic push aims to embed the company deeper into the lending ecosystem, analysts remain divided on whether it's enough to support its current valuation amid high debt and execution risks.
Keefe Bruyette & Woods raises its price target on Riot Platforms (RIOT) to $23, citing a new long-term agreement with AMD that provides revenue visibility and supports the company's high-performance computing strategy.
Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.
Western Digital's fiscal Q2 2026 results showcase robust growth, with revenue climbing 25% year-over-year to $3.0 billion. The company credits accelerating AI adoption for driving demand for its high-capacity nearline hard drives and advanced technologies like HAMR and UltraSMR.
Equifax closed 2025 with stronger-than-expected results, fueled by its Workforce Solutions and USIS divisions. While navigating a choppy mortgage landscape, the credit bureau is betting on proprietary data and AI to drive future growth, even as rising FICO royalty costs pressure reported margins.
As online ad costs surge, a technical revolution in user consent, pioneered in Europe, is quietly reshaping the global ad landscape. U.S. businesses, already grappling with state privacy laws, must integrate compliance with campaign performance to safeguard future marketing efficacy.
A waterfront condominium in Edgewater, N.J., has turned to forensic science to tackle a perennial urban problem: unscooped dog waste. By using DNA matching, property managers can identify—and fine—offending pet owners, sparking a debate over cost, privacy, and community standards.
Bitcoin and Ether claw back some losses following a sharp sell-off, though derivatives data suggests traders remain cautious. The bounce coincides with a broader market relief rally spurred by U.S. fiscal developments.
